Home

Martha Enger Lab

Professor Martha Enger

Welcome to the Brain Tumor Immunology & Therapy lab

The group is led by Dr Martha Chekenya Enger and is one of five labs that form the larger Translational Cancer Research Group

Publications (PubMed)

BTi - Moving Basic Research Closer To the Clinic

User involvement
Hjernesvulstforeningen besøker Brain tumor Immunology and Therapy Group hos Instituttet for biomedisin

Patient organization collaborates with researchers to improve brain cancer therapy

The research laboratory for brain cancer immunology and therapy at the Department of Biomedicine has received the secretary general of the Brain-Tumour Society Rolf Ledal to discuss current and future research projects.

Principal Investigator
Photo of Martha Chekenya Enger

Martha Chekenya Enger

Education: First-class Honours BSc Psychology from the University of Westminster, London, UK. Master of Science in Neuroscience from The Institute of Psychiatry/King's College, University of London. PhD at King's, Guy's, St Thomas' School of Medicine and Dentistry, University of...

Research project
Logo Hjernesvulstforeningen

Bortezomib and Temozolomide in Recurrent Glioblastoma With Unmethylated MGMT Promoter

This phase IB/II trial is designed to investigate the safety and survival benefits for patients with recurrent glioblastoma with unmethylated MGMT promoter treated with Bortezomib and Temozolomide in a specific schedule.

News
Aminur Raman

American Association for Cancer Research awards Aminur Rahman

Aminur Rahman, PhD, has been awarded the American Association for Cancer Research (AACR) Scholar-in-Training Award

News
Heading of journal

New paper in British Journal of Cancer

Our new paper "Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival" has been published in British Journal of Cancer.